Terms: = Lung cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
84791 results:
1. Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC.
Lu Y; Langerman SS; McCain E; Magee K; Maund SL; Srivastava MK; Samant M
JAMA Netw Open; 2024 May; 7(5):e249286. PubMed ID: 38700864
[TBL] [Abstract] [Full Text] [Related]
2. Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
[TBL] [Abstract] [Full Text] [Related]
3. Structural Racism as a Contributor to lung cancer Incidence and Mortality Rates Among Black Populations in the United States.
Robinson-Oghogho JN; Alcaraz KI; Thorpe RJ
Cancer Control; 2024; 31():10732748241248363. PubMed ID: 38698674
[TBL] [Abstract] [Full Text] [Related]
4. Radicality of mediastinal lymphadenectomy in minimally invasive pulmonary resection: a comparative analysis of uniportal and multiportal thoracoscopic approaches.
Tulinský L; Kepičová M; Ihnát P; Mitták M; Adamica D; Čierna L; Martínek L
Rozhl Chir; 2024; 103(2):48-56. PubMed ID: 38697813
[TBL] [Abstract] [Full Text] [Related]
5. lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors.
Lee G; Ahn A; Lee D; Kim TE; Kong S; Kang D; Kim HK; Shim YM; Cho J
Support Care Cancer; 2024 May; 32(5):322. PubMed ID: 38695959
[TBL] [Abstract] [Full Text] [Related]
6. Primary lung cancer in children and adolescents.
Chen Q; Cheng J; Wang L; Lv X; Hu J
J Cancer Res Clin Oncol; 2024 May; 150(5):225. PubMed ID: 38695944
[TBL] [Abstract] [Full Text] [Related]
7. Contrast-enhanced Imaging in Peripheral Pulmonary Lesions: The Role in US-guided Biopsies.
Wang XY; Yuan ZF; Gan KH; Zhong Y; Huang JX; Huang WJ; Xie YH; Pei XQ
Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230234. PubMed ID: 38695742
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis.
Gong S; Li Q; Yu X; Yang S
Front Immunol; 2024; 15():1362537. PubMed ID: 38694505
[TBL] [Abstract] [Full Text] [Related]
9. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
10. Metastasis of small cell lung cancer to bilateral extraocular muscles: a case report.
Ramalhão JP; Vieira BC; Rodrigues D; Afonso MG; Gouveia J; Baptista PM; Araújo M
J Med Case Rep; 2024 May; 18(1):216. PubMed ID: 38693545
[TBL] [Abstract] [Full Text] [Related]
11. Value of turbo spin echo-based diffusion-weighted imaging in the differential diagnosis of benign and malignant solitary pulmonary lesions.
Lei Q; Liu L; Li J; Yu K; Yin Y; Wang J; Su S; Song Y; Jiang G
Sci Rep; 2024 Apr; 14(1):9965. PubMed ID: 38693152
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
13. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract] [Full Text] [Related]
14. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
15. Stem-like CD8 T cells in stage I lung adenocarcinoma as a prognostic biomarker: A preliminary study.
Sang J; Liu P; Wang M; Xu F; Ma J; Wei Z; Ye X
J Cancer Res Ther; 2024 Apr; 20(2):669-677. PubMed ID: 38687939
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
[TBL] [Abstract] [Full Text] [Related]
17. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
[TBL] [Abstract] [Full Text] [Related]
18. The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
Zhang MS; Yeh YC; Huang HN; Lin LW; Huang YL; Wang LC; Yao LJ; Hung TC; Tseng YF; Lee YH; Liao WY; Shih JY; Hsieh MS
PLoS One; 2024; 19(4):e0301120. PubMed ID: 38687753
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic outcomes of radial endobronchial ultrasound bronchoscopy guided by manual navigation in the evaluation of peripheral pulmonary lesions: An observational study.
Yuan M; Hu Y; Wang L; Yin W; Xiao Y
Clin Respir J; 2024 May; 18(5):e13768. PubMed ID: 38685753
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy.
Fang F; Jia Z; Xie H; Cao Y; Zhu X; Yang XY; Guo X; Zhang H
Clin Respir J; 2024 May; 18(5):e13749. PubMed ID: 38685745
[TBL] [Abstract] [Full Text] [Related]
[Next]